Unither Pharmaceuticals Competitors and Similar CompaniesClear all

Unither Pharmaceuticals's competitors and similar companies include Northeast Pharmaceutical Group, Aurobindo Pharma, Servier and Glenmark Pharmaceuticals.

	Unither Pharmaceuticals Unither Pharmaceuticals is a company that engages in sterile unit-doses contract manufacturing.	Northeast Pharmaceutical Group Northeast Pharmaceutical Group (东北制药集团股份有) is a biotechnology company that provides medicinal and micro-ecological preparation products.	Aurobindo Pharma Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa.	Servier Servier, founded in 1954, is the first independent pharmaceutical group.	Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.
Founding Date	Founding Date 1993	Founding Date 1946	Founding Date 1986	Founding Date 1954	Founding Date 1977
Type	Type Subsidiary	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Amiens, FR HQ Wuhan Shi, CN Colomiers, FR Coutances, FR Gannat, FR see more	Locations Shen Yang Shi, CN HQ	Locations Hyderabad, IN HQ Hyderabad, IN South Brunswick Township, US	Locations Suresnes, FR HQ Sidi M'hamed, DZ Yerevan, AM Hawthorn, AU Melbourne, AU Vienna, AT Baku, AZ see more	Locations Mumbai, IN HQ Mumbai, IN
Employees	Employees 1,4801% increase	Employees 5,964	Employees 26,015	Employees 12,9983% increase	Employees 14,989
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹333.8b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) ₹131.5b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹134.9b (FY, 2026)	Cost of goods N/A	Cost of goods ₹46.7b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹206.6b (FY, 2026)	Gross profit N/A	Gross profit ₹87b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income ₹35b (FY, 2026)	Net income N/A	Net income ₹10.5b (FY, 2025)